Trial
NCT02288000
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospital, Lille
Collaborators
—
Condition
Alzheimer Disease
Intervention
Memantine
Why stopped
sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05